Argent Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Argent Advisors's GILD Position: Q1 2026 in Review
Argent Advisors reduced its Gilead Sciences (GILD) stake by 0.36% in Q1 2026, selling an estimated $5.74K and leaving 11,495 shares worth $1.6M. The position accounts for 0.44% of the portfolio, ranked #60.
Argent Advisors first reported a position in GILD in Q4 2019 and has held it in 18 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Argent Advisors held 11,495 shares of Gilead Sciences worth $1.6M as of Q1 2026.
- Argent Advisors sold 41 Gilead Sciences shares in Q1 2026, an estimated $5.74K.
- Gilead Sciences made up 0.44% of Argent Advisors's portfolio in Q1 2026, its #60 holding.
- Argent Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 18 quarters since.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Argent Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.